Following menopause, women exhibit an increased prevalence of dyslipidemia, especially high levels of LDL-C and TC, which can lead to CVD.[6] Previous studies have focused on the relationship between dyslipidemia and estrogen deficiency in postmenopausal women; however, recent studies have found that endogenous estrogens are not independent predictors of lipid levels in postmenopausal women.[3] In our study, the estrogen levels were not statistically different among the different FSH quartiles. Here, BRD2 is linked to metabolic syndrome.